Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “Focal Seizure”
Phase 3 2
- RAP-219Rapport Therapeutics, Inc.Focal Seizure
- VormatroginePraxis Precision Medicines, Inc.Focal Seizure
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.